For: | Sato-Espinoza K, Chotiprasidhi P, Huaman MR, Díaz-Ferrer J. Update in lean metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2024; 16(3): 452-464 [PMID: 38577539 DOI: 10.4254/wjh.v16.i3.452] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v16/i3/452.htm |
Number | Citing Articles |
1 |
Lampros Chrysavgis, Evangelos Cholongitas. From NAFLD to MASLD: what does it mean?. Expert Review of Gastroenterology & Hepatology 2024; 18(6): 217 doi: 10.1080/17474124.2024.2374472
|
2 |
Karina Sato-Espinoza, Perapa Chotiprasidhi, Estefanía Liza, Zuly Placido-Damian, Javier Diaz-Ferrer. Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time. World Journal of Transplantation 2024; 14(4): 98718 doi: 10.5500/wjt.v14.i4.98718
|